New test tracks immune response to MS drug in small study
NCT ID NCT06310343
First seen Mar 06, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This study involved 15 people with multiple sclerosis who were already taking the drug alemtuzumab. Researchers wanted to see if the body makes antibodies against the drug and how those antibodies change over 24 months. The goal was to learn more about how these antibodies might affect treatment and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barts Health NHS Trust
London, Second Floor Neurophys Dept, United Kingdom
Conditions
Explore the condition pages connected to this study.